Scorpion Envenomation

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Haffkine Biopharmaceuticals
1 program
1
Antiscorpion venom serumPhase 31 trial
Active Trials
NCT00753064CompletedEst. Dec 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Haffkine BiopharmaceuticalsAntiscorpion venom serum

Clinical Trials (1)

AScVS and/ or Prazosin for Scorpion Envenomation

Start: Sep 2006Est. completion: Dec 2007
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space